XML 55 R45.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies - Segment Information (Details)
$ in Thousands
3 Months Ended
Sep. 30, 2017
USD ($)
segment
Sep. 30, 2016
USD ($)
Medical Indication Information    
Contract manufacturing revenue $ 3,591 $ 5,063
Net sales $ 154,961 161,559
Segment information    
Number of Reportable Segments | segment 1  
Antibiotic    
Medical Indication Information    
Net sales $ 3,349 3,780
Anti-Psychosis    
Medical Indication Information    
Net sales 14,991 17,320
Cardiovascular    
Medical Indication Information    
Net sales 11,306 12,694
Central Nervous System    
Medical Indication Information    
Net sales 8,818 10,350
Gallstone    
Medical Indication Information    
Net sales 6,564 12,883
Gastrointestinal    
Medical Indication Information    
Net sales 14,553 18,052
Glaucoma    
Medical Indication Information    
Net sales 2,668 5,783
Migraine    
Medical Indication Information    
Net sales 15,015 7,160
Muscle Relaxant    
Medical Indication Information    
Net sales 3,791 3,532
Pain Management    
Medical Indication Information    
Net sales 5,761 6,608
Respiratory    
Medical Indication Information    
Net sales 1,647 2,213
Thyroid Deficiency    
Medical Indication Information    
Net sales 47,214 39,838
Urinary    
Medical Indication Information    
Net sales 2,997 5,101
Other    
Medical Indication Information    
Net sales $ 12,696 $ 11,182